On August 26, 2025 BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, reported it will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on September 8, 2025, with a fireside chat at 1:50 p.m. EDT (Press release, BeOne Medicines, AUG 26, 2025, View Source/news/beone-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference/130baabb-28b4-4d62-a366-d2e4048a52b7" target="_blank" title="View Source/news/beone-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference/130baabb-28b4-4d62-a366-d2e4048a52b7" rel="nofollow">View Source [SID1234655488]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The live webcast of this event can be accessed from the investors section of the Company’s website at View Source, View Source, View Source An archived webcast will be available on the Company’s website.